ANALYST INTERVIEW: INVESTING IN BIOTECHNOLOGY: BILL TANNER - SG COWEN.(MAK903) INVESTING IN BIOTECHNOLOGY: BILL TANNER - SG COWEN. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 6/7/01. Tickers featured: ABSC ABSC Association des Bibliothèques de la Santé du Canada (Canadian Health Libraries Association) ABSC Alaska Biological Science Center ABSC Albany-Berkeley Soccer Club ABSC Active Business Software Consultancy , BGEN BGen abbr. brigadier general , CEPH CEPH Council on Education for Public Health CEPH Centre d'Etude du Polymorphisme Humain , DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. , GENZ, HGSI, ICOS, IMCL, IMNX, JNJ, LLY, MEDI, MLNM, MRK, OSIP, PDLI, RSTA, TKTX, VRTX, XOMA. Complete text approximately 3000 words. Document # MAK903. ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com. *** |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion